Cancer Query

DRUGSURV is based on 44 clinical cancer expression datasets covering 17 different cancers. Table C1 reports available cancer types. You can view top associated drugs for each cancer (click the link "View top Drugs"). Table C2 reports available datasets. You can view top associated drugs for each dataset (click the link "View top Drugs").

Table C1. Cancer types

# Cancer Type Number of Expression Datasets View Associated Drugs
1 breast cancer 17 View top Drugs
2 lung cancer 7 View top Drugs
3 ovarian cancer 4 View top Drugs
4 hepatocellular carcinoma 2 View top Drugs
5 colon cancer 2 View top Drugs
6 chronic lymphocytic leukemia 2 View top Drugs
7 bladder cancer 1 View top Drugs
8 meningioma 1 View top Drugs
9 liposarcoma 1 View top Drugs
10 prostate cancer 1 View top Drugs
11 urothelial carcinomas 1 View top Drugs
12 diffuse large b cell lymphoma 1 View top Drugs
13 high-grade glioma 1 View top Drugs
14 glioblastoma 1 View top Drugs
15 cervical cancer 1 View top Drugs
16 astrocytic gliomas 1 View top Drugs
17 multiple myeloma 1 View top Drugs

Table C2. Clinical expression datasets

# GEO Dataset Cancer Type View Associated Drugs
1 a compact vegf signature associated with distant metastases and poor outcomes breast cancer View top Drugs
2 discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer breast cancer View top Drugs
3 analysis of early primary breast cancer to identify prognostic markers and associated pathways: mrna and mirna profiling breast cancer View top Drugs
4 183 breast tumors from the helsinki univerisity central hospital with survival information breast cancer View top Drugs
5 search for a gene-expression signature of breast cancer local recurrence in young women breast cancer View top Drugs
6 molecular characterization of breast cancer subtypes derived from joint analysis of high throughput mirna and mrna data breast cancer View top Drugs
7 validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer breast cancer View top Drugs
8 heterogeneity of response to chemotherapy and recurrence-free survival in neoadjuvant breast cancer: results from the i-spy 1 trial breast cancer View top Drugs
9 gene expression of breast cancer tissue in a large population-based cohort of swedish patients breast cancer View top Drugs
10 strong time dependence of the 76-gene prognostic signature breast cancer View top Drugs
11 a gene expression signature identifies two prognostic subgroups of basal breast cancer breast cancer View top Drugs
12 gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis breast cancer View top Drugs
13 an expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival breast cancer View top Drugs
14 the humoral immune system has a key prognostic impact in node-negative breast cancer breast cancer View top Drugs
15 down-regulation of ecrg4, a candidate tumor suppressor gene in human breast cancer breast cancer View top Drugs
16 breast cancer relapse free survival breast cancer View top Drugs
17 endocrine sensitivity index validation dataset breast cancer View top Drugs
18 expression profile-defined classification of lung adenocarcinoma lung cancer View top Drugs
19 gene expression data for pathological stage i-ii lung adenocarcinomas lung cancer View top Drugs
20 relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis lung cancer View top Drugs
21 human lung adenocarcinoma lung cancer View top Drugs
22 a gene expression signature to predict metastasis and survival in non-small cell lung cancer lung cancer View top Drugs
23 gene expression signatures for predicting prognosis of squamous cell lung carcinomas lung cancer View top Drugs
24 expression data for early stage nsclc lung cancer View top Drugs
25 a prognostic gene expression index in ovarian cancer ovarian cancer View top Drugs
26 survival related profile, pathways and transcription factors in ovarian cancer ovarian cancer View top Drugs
27 prediction of progression-free survival in patients with advanced-stage serous ovarian cancer ovarian cancer View top Drugs
28 a gene signature predicting for survival in suboptimally debulked patients with ovarian cancer ovarian cancer View top Drugs
29 gene expression in fixed tissues and outcome in hepatocellular carcinoma hepatocellular carcinoma View top Drugs
30 combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma hepatocellular carcinoma View top Drugs
31 metastasis gene expression profile predicts recurrence and death in colon cancer patients (moffitt samples) colon cancer View top Drugs
32 experimentally derived metastasis gene expression profile predicts recurrence and death in colon cancer patients colon cancer View top Drugs
33 expression data from untreated cll patients chronic lymphocytic leukemia View top Drugs
34 an eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia chronic lymphocytic leukemia View top Drugs
35 predective value of prognosis-related gene expression study in primary bladder cancer bladder cancer View top Drugs
36 human meningioma fixed tumour tissue meningioma View top Drugs
37 whole-transcript expression data for liposarcoma liposarcoma View top Drugs
38 molecular sampling of prostate cancer: a dilemma for predicting disease progression prostate cancer View top Drugs
39 subtype classification, grading, and outcome prediction of urothelial carcinomas by combined mrna profiling and acgh urothelial carcinomas View top Drugs
40 prediction of survival in diffuse large b cell lymphoma treated with chemotherapy plus rituximab diffuse large b cell lymphoma View top Drugs
41 molecular subclasses of high-grade glioma: prognosis, disease progression, and neurogenesis high-grade glioma View top Drugs
42 gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age glioblastoma View top Drugs
43 cervical cancer cervical cancer View top Drugs
44 genome-wide profiling of astrocytic gliomas astrocytic gliomas View top Drugs
45 maqc-ii project: multiple myeloma (mm) data set multiple myeloma View top Drugs


Feel free to use our tools at bioprofiling.de: